Literature DB >> 1452295

Fasting insulin in relation to subsequent blood pressure changes and hypertension in women.

L Lissner1, C Bengtsson, L Lapidus, K Kristjansson, H Wedel.   

Abstract

The role of hyperinsulinemia in the development of hypertension is not well understood, particularly insofar as both conditions relate to obesity. The present analysis examines the hypothesis that hyperinsulinemia, independent of obesity, precedes hypertension and natural blood pressure increases in women. The subjects were 50-year-old women from a prospective population study in Gothenburg, Sweden. Fasting insulin levels were determined at baseline (1968-1969) and were evaluated in relation to subsequent hypertension. Blood pressures were measured at the initial physical examination and at the 6- and 12-year follow-up examinations. The first analysis presented here (n = 278) identified incident cases of hypertension during the 12-year follow-up period, whereas the second analysis (n = 219) examined continuous changes in blood pressure. In both analyses, degree, type, and changes in obesity were considered as possible confounding factors. High fasting insulin values were predictive of subsequent incidence of hypertension over the 12-year follow-up period. Subjects with insulin values above the 75th percentile experienced three times more hypertension than did those below the 25th percentile. There was also a significant association between insulin at baseline and increases in diastolic (but not systolic) blood pressure. The positive relations between fasting insulin, on one hand, and diastolic blood pressure changes and hypertension, on the other, could not be explained by confounding effects of body mass index, waist/hip ratio, or weight gain. These findings are consistent with the hypothesis that fasting insulin levels may be one predisposing factor in the etiology of hypertension.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1452295     DOI: 10.1161/01.hyp.20.6.797

Source DB:  PubMed          Journal:  Hypertension        ISSN: 0194-911X            Impact factor:   10.190


  11 in total

1.  Insulin resistance and risk of incident hypertension among men.

Authors:  Tai-Shuan Lai; Gary C Curhan; John P Forman
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-09       Impact factor: 3.738

2.  Increased C-reactive protein is associated with future development of diabetes mellitus in essential hypertensive patients.

Authors:  Chiung-Mei Weng; Chang-Hua Chou; Yao-Yi Huang; Chih-Chan Lin; Yen-Wen Liu; Wei-Chuan Tsai
Journal:  Heart Vessels       Date:  2010-07-31       Impact factor: 2.037

3.  Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance.

Authors: 
Journal:  Hypertension       Date:  2002-11       Impact factor: 10.190

4.  Sex-specific relations between fasting insulin, insulin resistance and incident hypertension: 8.9 years follow-up in a Middle-Eastern population.

Authors:  B Arshi; M Tohidi; A Derakhshan; S Asgari; F Azizi; F Hadaegh
Journal:  J Hum Hypertens       Date:  2014-08-28       Impact factor: 3.012

Review 5.  Role of hypertension in the metabolic syndrome: who is affected?

Authors:  Gladys Velarde; Bradford C Berk
Journal:  Curr Hypertens Rep       Date:  2005-12       Impact factor: 5.369

6.  Pioglitazone opposes neurogenic vascular dysfunction associated with chronic hyperinsulinaemia.

Authors:  S Takatori; Y Zamami; N Yabumae; N Hanafusa; M Mio; T Egawa; H Kawasaki
Journal:  Br J Pharmacol       Date:  2008-02-04       Impact factor: 8.739

7.  Fasting insulin concentrations and incidence of hypertension, stroke, and coronary heart disease: a meta-analysis of prospective cohort studies.

Authors:  Pengcheng Xun; Ying Wu; Qianchuan He; Ka He
Journal:  Am J Clin Nutr       Date:  2013-10-16       Impact factor: 7.045

8.  World congress on insulin resistance, diabetes, and cardiovascular disease: Part 1.

Authors:  Zachary T Bloomgarden
Journal:  Diabetes Care       Date:  2011-07       Impact factor: 19.112

Review 9.  Hypertension and the cardiometabolic syndrome.

Authors:  Camila Manrique; Guido Lastra; Adam Whaley-Connell; James R Sowers
Journal:  J Clin Hypertens (Greenwich)       Date:  2005-08       Impact factor: 3.738

Review 10.  Insulin resistance, hypertension, and coronary heart disease.

Authors:  Gerald Reaven
Journal:  J Clin Hypertens (Greenwich)       Date:  2003 Jul-Aug       Impact factor: 3.738

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.